Product Images Nifedipine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Nifedipine NDC 53808-1118 by Doh Central Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
MEAN REDUCTIONS IN TROUGH SUPINE BLOOD PRESSURE (mmHg) for Nifedipine ER extended-release tablets at different doses (30mg, 60mg, 90mg) reported in two studies. Study 1 shows reductions in systolic/diastolic pressures with doses of 30mg, 60mg, and 90mg. Study 2 also presents reductions in systolic/diastolic pressures with doses of 30mg, 60mg, and 90mg. The text also clarifies that Nifedipine ER is Nifedipine extended-release tablets.*
This is a table showing the percentage of patients experiencing certain adverse effects while taking nifedipine extended-release tablets compared to a placebo. The adverse effects include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The number of patients (n) included in the study for each group is also provided.*
These are Novast strength color markings for different dosages: 30 mg (yellow color with "Novast" on one side and "33" on the other), 60 mg (pink color with "Novast" on one side and "36" on the other), and 90 mg (brown color with "Novast" on one side and "39" on the other).*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.